Jun 2026 (Q3 FY26) — Jul 30, 2026
Dolby Laboratories Q3 FY26 — Strong Q4 Outlook Driven by VDP and Auto Momentum
Read the full callDolby Laboratories earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 305 | −3.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 11.3 | −3.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 28.6 | −37.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
31 of 31 judged targets kept · 48 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| First Dolby Vision 2 TVs in market | first TVs in market by the end of 2026 | Sep 2025 | On TVs, Dolby Vision 2 is now in market with some Hisense TVs | Achieved |
| Non-GAAP earnings per share | $4.19 to $4.34 | Sep 2025 | We expect non-GAAP earnings per share to be between $4.25 and $4.40 | Revised Down |
| Broadcast licensing revenue growth | up mid-single digits | Sep 2025 | broadcast to be up mid-single digits due to higher recoveries and imaging patents | On Track |
48 of Dolby Laboratories, Inc.'s 79 targets are still open. See which are on track and which have gone quiet. The 3 above are the free sample; 76 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $69.11 on 14 Oct 2025 → $60.83. High $69.58 (21 Oct 2025), low $48.51 (14 Jul 2026).
Overview
Guidance
31 of 31 judged targets kept · 48 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| First Dolby Vision 2 TVs in market | first TVs in market by the end of 2026 | Sep 2025 | On TVs, Dolby Vision 2 is now in market with some Hisense TVs | Achieved |
| Non-GAAP earnings per share | $4.19 to $4.34 | Sep 2025 | We expect non-GAAP earnings per share to be between $4.25 and $4.40 | Revised Down |
| Broadcast licensing revenue growth | up mid-single digits | Sep 2025 | broadcast to be up mid-single digits due to higher recoveries and imaging patents | On Track |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 79 tracked commitments, with each call’s wording and source.
Call summaries
Dolby Laboratories Q3 FY26 — Strong Q4 Outlook Driven by VDP and Auto Momentum
Read the full callDolby Q2 FY26 — Strong Content Adoption and Maintained Full-Year Guidance
Read the full callEvery analysed call
Financials
Net profit, year on year: −38% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 305 | 357 | 370 | 316 | 307 | 347 | 396 | 305 |
| Operating profit | 46 | 80 | 108 | 48 | 30 | 62 | 113 | 34 |
| Operating margin | 15.2% | 22.4% | 29.2% | 15.1% | 9.7% | 17.9% | 28.6% | 11.3% |
| Other income | 13 | 6 | 12 | 8 | 12 | 9 | 7 | 9 |
| Profit before tax | 60 | 86 | 120 | 56 | 42 | 72 | 120 | 44 |
| Tax rate | 1.4% | 20.9% | 23.3% | 16.2% | −19.2% | 25.0% | 20.3% | 33.3% |
| Net profit | 59 | 68 | 92 | 46 | 49 | 53 | 95 | 29 |
| EPS ($ per share) | — | 0.71 | 0.95 | 0.48 | — | 0.56 | 1 | 0.30 |
| Line item | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Reserves | 2,314 | 2,328 | 2,443 | 2,608 | 2,298 | 2,392 | 2,496 | 2,635 |
| Total liabilities | 495 | 509 | 479 | 501 | 439 | 608 | 623 | 596 |
| Fixed assets | 514 | 537 | 542 | 534 | 513 | 482 | 479 | 471 |
| Investments | 178 | 119 | 47 | 39 | 189 | 139 | 0 | 1 |
| Total assets | 2,865 | 2,822 | 2,917 | 3,106 | 2,690 | 2,980 | 3,110 | 3,228 |
| Line item | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 352 | 328 | 344 | 448 | 319 | 367 | 327 | 472 |
| Cash from investing | 78 | -56 | 134 | -45 | -296 | 54 | -286 | -11 |
| Cash from financing | -134 | -385 | -208 | -253 | -611 | -237 | -288 | -247 |
| Net cash flow | 291 | -120 | 274 | 153 | -605 | 190 | -240 | 216 |
| Capital expenditure | -73 | -96 | -66 | -54 | -48 | -30 | -30 | -36 |
| Free cash flow | 279 | 231 | 278 | 393 | 271 | 337 | 297 | 436 |
| Segment | Q2 FY2024 | Q3 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Reportable | — | — | — | — | — | 100% | 100% | 100% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Q3 FY2026 · share of revenue
As DLB cuts its regions in its filings; they can nest, so they need not add to 100%.
95 filings between Nov 20, 2025 and Oct 1, 2026.
Purchases
None
No insider bought shares.
Sales
$14.67M
38 sales by 9 insiders
82% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 4 gifts, 3 conversions.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| YEAMAN KEVIN J | — | $7.00M | Dec 17, 2025 |
| Couling John D | — | $4.27M | Oct 1, 2026 |
| SHERMAN MARK ANDREW | — | $1.08M | Dec 17, 2025 |
| Revankar Shriram | — | $747.9K | Aug 14, 2026 |
| Pendleton Todd | — | $647.9K | May 22, 2026 |
| Nicholson Ryan | — | $359.5K | Aug 25, 2026 |
| Park Robert J | — | $277.4K | May 12, 2026 |
| Prophet Tony A | — | $223.9K | Nov 25, 2025 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 6,831 | $401.1K |
| Oct 1, 2026 | Couling John D SVP, Entertainment | Option exercise 10b5-1 plan | 7,667 | $348.8K |
| Oct 1, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 836 | $49.6K |
| Sep 15, 2026 | SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | Award | 48,076 | $0 |
| Sep 15, 2026 | Couling John D SVP, Entertainment | Award | 48,076 | $0 |
| Sep 15, 2026 | Whitten Marc President and CEO | Award | 160,256 | $0 |
| Sep 1, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 7,667 | $468.0K |
| Sep 1, 2026 | Couling John D SVP, Entertainment | Option exercise 10b5-1 plan | 7,667 | $348.8K |
| Aug 28, 2026 | Dolby Dagmar 10% owner | Gift | 300,000 | $0 |
| Aug 28, 2026 | Dolby Dagmar 10% owner | Conversion | 300,000 | $0 |
| Aug 25, 2026 | Nicholson Ryan VP, CAO and Corp. Controller | Sale | 1,183 | $77.2K |
| Aug 14, 2026 | Revankar Shriram SVP, Advanced Technology Group | Sale 10b5-1 plan | 3,000 | $188.1K |
| Aug 10, 2026 | Nicholson Ryan VP, CAO and Corp. Controller | Sale | 1,348 | $83.6K |
| Aug 4, 2026 | Nicholson Ryan VP, CAO and Corp. Controller | Sale | 357 | $21.6K |
| Aug 3, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 6,884 | $413.8K |
| Aug 3, 2026 | Couling John D SVP, Entertainment | Option exercise 10b5-1 plan | 7,667 | $348.8K |
| Aug 3, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 783 | $46.2K |
| Jul 1, 2026 | Couling John D SVP, Entertainment | Option exercise 10b5-1 plan | 7,667 | $348.8K |
| Jul 1, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 7,667 | $407.9K |
| Jun 1, 2026 | Couling John D SVP, Entertainment | Option exercise 10b5-1 plan | 7,666 | $348.8K |
| Jun 1, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 508 | $28.5K |
| Jun 1, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 7,158 | $397.9K |
| May 22, 2026 | Pendleton Todd SVP, Chief Marketing Officer | Sale | 11,876 | $647.9K |
| May 18, 2026 | Revankar Shriram SVP, Advanced Technology Group | Tax withheld 10b5-1 plan | 4,329 | $234.7K |
| May 15, 2026 | Revankar Shriram SVP, Advanced Technology Group | Sale 10b5-1 plan | 3,000 | $164.7K |
| May 12, 2026 | Park Robert J SVP & Chief Financial Officer | Sale 10b5-1 plan | 391 | $22.4K |
| May 12, 2026 | Park Robert J SVP & Chief Financial Officer | Sale 10b5-1 plan | 4,504 | $255.0K |
| May 5, 2026 | Couling John D SVP, Entertainment | Option exercise 10b5-1 plan | 7,666 | $348.8K |
| May 5, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 738 | $43.1K |
| May 5, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 6,928 | $398.2K |
| May 4, 2026 | Couling John D SVP, Entertainment | Sale 10b5-1 plan | 4,688 | $274.1K |
| Apr 1, 2026 | Rollins Emily Director | Sale 10b5-1 plan | 1,000 | $60.1K |
| Feb 25, 2026 | Dolby Dagmar 10% owner | Conversion | 10,000 | $0 |
| Feb 25, 2026 | Dolby Dagmar 10% owner | Gift | 10,000 | $0 |
| Feb 17, 2026 | Revankar Shriram SVP, Advanced Technology Group | Sale 10b5-1 plan | 3,000 | $198.4K |
| Feb 13, 2026 | Nicholson Ryan VP, CAO and Corp. Controller | Option exercise | 2,667 | $121.3K |
| Feb 13, 2026 | Nicholson Ryan VP, CAO and Corp. Controller | Sale | 2,667 | $177.0K |
| Feb 11, 2026 | Dolby Dagmar 10% owner | Gift | 380,000 | $0 |
| Feb 11, 2026 | Dolby Dagmar 10% owner | Conversion | 380,000 | $0 |
| Feb 3, 2026 | Sud Anjali Director | Award | 3,908 | $0 |
| Feb 3, 2026 | Prophet Tony A Director | Award | 3,908 | $0 |
| Feb 3, 2026 | GOTCHER PETER C Director | Award | 3,908 | $0 |
| Feb 3, 2026 | TEVANIAN AVADIS Director | Award | 3,908 | $0 |
| Feb 3, 2026 | Rollins Emily Director | Award | 3,908 | $0 |
| Feb 3, 2026 | Segars Simon Director | Award | 3,908 | $0 |
| Feb 3, 2026 | Dolby David Director | Award | 3,908 | $0 |
| Feb 2, 2026 | Couling John D SVP, Entertainment | Sale | 6,667 | $432.6K |
| Dec 17, 2025 | SHERMAN MARK ANDREW EVP, Gen. Counsel & Secretary | Sale 10b5-1 plan | 2,491 | $167.6K |
| Dec 17, 2025 | YEAMAN KEVIN J President and CEO | Sale 10b5-1 plan | 6,671 | $448.5K |
| Dec 17, 2025 | YEAMAN KEVIN J President and CEO | Sale 10b5-1 plan | 80 | $5.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Dolby Laboratories, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading